It is a therapy to rebuild (regenerate) enamel lost due to carious lesion by non-invasive introduction of peptide implants. The peptides are analogs of human amelogenin protein that naturally produces enamel from minerals during embryogenesis.
It's called enamel "implantation" to stress that we actually implant protein matrix that re-builds enamel from patient's salive minerals within a month. However, in clinics it's a simple tooth hygienic procedure (non invasive, just add one drop on enamel).
When implanted into initial caries lesion, INNODENT™ products form a fibrillary biomatrix and attract tooth minerals from human saliva to rebuild the lost enamel. As a result, in a period of few weeks new enamel crystallites and prisms are formed. Since it is based on amelogenin proteins, it mimics natural enamel formation process (odonotgenesis).
Utilizing the above-mentioned mechanism, INNODENT™ peptides stimulate natural regeneration of enamel from inside.
INNODENT™ enamel implantation therapy is completely non-invasive, pain and hassle free. It takes 15 minutes to treat up to 5 teeth.
Indications for treatment:
InnoDent works perfect in both deciduous and permanent teeth.
Remineralization with fluoride & other mineral products is a well-acknowledged preventive measure in caries progression. However, it does not induce re-building of new structural elements inside the carious lesion.
Regeneration by INNODENT™ technology works perfectly both in tooth enamel and dentine. During dentine treatment, however, etching should not be done.
For initial white spots caries and enamel cracks, single procedure is enough to obtain permanent results.
To optimize treatment of enamel hypoplaisa or amelogenesis imperfecta, this implantation procedure can be performed once every 3 months
Single active component is biocompatible synthetic analog of human amelogenin protein trademarked as INNODENT™.
1)Fang P. A., Conway J. F., Margolis H. C., Simmer J. P., Beniash E. (2011). Hierarchical self-assembly of amelogenin and the regulation of biomineralization at the nanoscale. Proc. Natl. Acad. Sci. U.S.A. 108, 14097–14102 10.1073/pnas.1106228108 [PMC free article]
2)Fang P. A., Margolis H. C., Conway J. F., Simmer J. P., Beniash E. (2013). CryoTEM study of effects of phosphorylation on the hierarchical assembly of porcine amelogenin and its regulation of mineralization in vitro. J. Struct. Biol. 183, 250–257 10.1016/j.jsb.2013.05.011 [PMC free article]
3)J Dent Res. 1979 Mar;58(Spec Issue B):871-82. Matrix and mineral changes in developing enamel. Robinson C, Briggs HD, Atkinson PJ, Weatherell JA.
4)Matthias Hannig & Christian Hannig (2010). Nanomaterials in preventive dentistry. Nature Nanotechnology 5, 565–569 (2010)
5)Full-length amelogenin influences the differentiation of human dental pulp stem cells. Frasheri I, Ern C, Diegritz C, Hickel R, Hristov M, Folwaczny M. Stem Cell Res Ther. 2016 Jan 13;7(1):10. doi: 10.1186/s13287-015-0269-9. PMID: 26762641 Free PMC Article
6)Amelogenin in Enamel Tissue Engineering. Uskoković V. Adv Exp Med Biol. 2015;881:237-54. doi: 10.1007/978-3-319-22345-2_13. PMID: 26545753 Free PMC Article
7)Matrix Biol. 2001 Sep;20(5-6):307-16. Is there more to enamel matrix proteins than biomineralization? Zeichner-David M1.
8)Инновационный метод лечения начального кариеса у детей препаратом InnoDent. Замураева, Айтуов, Егизбекова. Concept Стоматология. 2016
9) Novel Early Caries Treatment Method in Children with InnoDent™ Preparations. Інноваційний метод лікування початкового карієсу у дітей препаратом InnoDent™ , «Профілактична та дитяча стоматологія», №1 (14) 2016, с. 47-51
10) Novel Early Caries Treatment Method in Children with InnoDent™ Preparations. INTERNATIONAL DENTAL JOURNAL. Abstracts of 104th FDI Annual Dental Congress, Vol 66, Suppl 1, 2016.
Manufacturing of INNODENT™ products is carried out in compliance with GMP standards in largest Swiss Biotech corporation Bachem AG. Each InnoDent vial consists of synthetic biopolymer only.
INNODENT™ products also comply with local regulations for oral care products (Customs Union Declaration 009/2011.